Search results
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 2 days agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
Tracking dog licenses challenges town clerks
Valley News· 6 days agoOwners of all dogs 6 months of age or older in Vermont are required to annually renew their license with their town of residence. Beginning April 1,...
Susie Lee-related account acquires Rheinmetall AG stock By Investing.com
Investing.com· 7 days agoA recent congressional trade report disclosed that Susie Lee, a member of Congress representing...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased to announce that Truqap™ (capivasertib) in combination with fulvestrant is
Regal Rexnord (NYSE:RRX) Price Target Cut to $181.00 by Analysts at Barclays
ETF DAILY NEWS· 14 hours agoRegal Rexnord (NYSE:RRX – Free Report) had its price objective cut by Barclays from $199.00 to $181.00 in a report published on Tuesday morning, Benzinga reports. They currently have an overweight ...
The Unexpected Connection Between Brewing Coffee a | Newswise
Newswise· 3 days agoIn 1883 Osborne Reynolds injected ink into water in a short, clear pipe to observe its movement. For...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 2 days agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...
Origins of Welsh dragons finally exposed by expert | Newswise
Newswise· 7 days agoA large fossil discovery has helped shed light on the history of dinosaurs in Wales. Until recently,...
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead...
Benzinga· 3 days agoStrasbourg, France, June 3, 2024, 7:30 a.m. CET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the ...
FLASH FRIDAY: Evaluating Access Fees Proposal - Traders Magazine
Traders Magazine· 5 days agoFLASH FRIDAY is a weekly content series looking at the past, present and future of capital markets...
